tiprankstipranks
Trending News
More News >

Sandeep Laumas Insider Profile

4 Followers
Sandeep Laumas, Director at Bioxcel Therapeutics, holds ― shares in Bioxcel Therapeutics (Ticker: BTAI), holds 0.00 shares in Instil Bio (Ticker: TIL), holds 818.77K shares in 9 Meters Biopharma (Ticker: NMTRQ). Most recently, Sandeep Laumas ― shares of Bioxcel Therapeutics on ― for an estimated value of ―.
tipranks
Sandeep Laumas

Sandeep Laumas
Bioxcel Therapeutics (BTAI)
Director

Ranked #100,040 out of 103,431 Corporate Insiders

Profitable Transactions

0%
0 out of 8 Profitable Transactions

Average Return

-66.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Sandeep Laumas does not currently own shares as a corporate insider.
A breakdown of Sandeep Laumas's holdings

Insider Roles

Bioxcel Therapeutics
(BTAI)
Director
9 Meters Biopharma
(NMTRQ)
Director
Instil Bio
(TIL)
CFO and CBO
Unicycive Therapeutics
(UNCY)
Director
Roles that Sandeep Laumas holds in companies

Most Profitable Insider Trade

Stock:
9 Meters Biopharma
(NMTRQ)
Rating:Informative Buy
Date:Jul 01, 2019 - Jul 01, 2020
Return:-38.00%
The most profitable trade made by Sandeep Laumas

Sandeep Laumas's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Bioxcel Therapeutics
Director
9 Meters Biopharma
Jul 02, 2020
Director
Uninformative Buy
Instil Bio
Sep 12, 2025
CFO and CBO
Uninformative Buy
362.04K
$0.00
Unicycive Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Sandeep Laumas's performance on stock

Sandeep Laumas insider profile FAQ

What is the percentage of profitable transactions made by Sandeep Laumas?
The percentage of profitable transactions made by Sandeep Laumas is 0%.
    What is the average return per transaction made by Sandeep Laumas?
    The average return per transaction made by Sandeep Laumas is -66.10%.
      What stocks does Sandeep Laumas hold?
      Sandeep Laumas holds: BTAI, NMTRQ, TIL, UNCY stocks.
        What was Sandeep Laumas’s latest transaction?
        Sandeep Laumas latest transaction was an Uninformative Buy of ―.
          What was Sandeep Laumas's most profitable transaction?
          Sandeep Laumas’s most profitable transaction was an Informative Buy of NMTRQ stock on July 1, 2019. The return on the trade was -38.00%.
            What is Sandeep Laumas's role in Bioxcel Therapeutics?
            Sandeep Laumas's role in Bioxcel Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.